ALERTS100%to10000%GAIN
6年前
MDECHEM, INC., a Research and Development company now focusing its efforts to the development of medical applications based on its proprietary technology. Resources are dedicated to the development of new products that have significant uses in the human and animal health care fields. Business strategy emphasis is in seeking strategic alliances and working with companies already involved in the manufacture and commercialization of human medical applications and veterinary medicine. The successful development of the Phosfamid Technology, subsequently sold to Envirofuels, L.P. , provide MDECHEM, INC. the opportunity of future cash flows resulting from its interest in the limited partnership. Product development, testing and clinical studies are conducted by MDECHEM’s subsidiary, MED QUIMICA, S.A., of San Jose, Costa Rica.
adijas
9年前
New mail from ceo.
'MDEChem, Inc. and MaxHeal, Inc. will in January 2016 be providing to all shareholders of record an update and report of our activity in 2013, 2014 and. 2015. In addition this report will detail our plans for both companies in 2016 and their sales projections.'
Company got a patent september 22 http://www.mdechem.com/CorporateInfo.html
New website fot Maxheal http://www.maxheal.com/
Authorized shares: 100,000,000
Issued Shares: 22,218,167
Non-restricted shares in float: 16,625,005
Last news was in 2007 and company stopped filing in 2012.
adijas
9年前
Mail from CEO Paul Sack: 'We will be releasing a comprehensive look at the MDEChem and MaxHeal companies in mid-November 2015. We have used our income for the past 3 years for research and development of our products. Our accountant will be preparing the proper information for the OTC next spring.'
Looks like company is ready to hit the market again after some difficult years.
As you can see company got a patent september 22 http://www.mdechem.com/CorporateInfo.html
And they have a new website fot Maxheal http://www.maxheal.com/
Authorized shares: 100,000,000
Issued Shares: 22,218,167
Non-restricted shares in float: 16,625,005
Last news was in 2007 and company stopped filing in 2012.
Stock traded at 2 dollars 15 years ago and at 0,8 10 years ago. After MDKM stopped releasing news PPS dropped to current price. So lots of potential on the upside.